Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Guha Website

Udayan Guha, M.D., Ph.D.

Selected Publications

1)  Kelly RJ, Thomas A, Rajan A, Chun G, Lopez-Chavez A, Szabo E, Spencer S, Carter CA, Guha U, Khozin S, Poondru S, Van Sant C, Keating A, Steinberg SM, Figg W, Giaccone G.
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
Ann. Oncol. 24: 2601-6, 2013.
[Journal]
2)  Kurochkina N, Guha U.
SH3 domains: modules of protein-protein interaction.
Biophysical Rev. 5: 29-39, 2013.
Full Text Article. [Journal]
3)  Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M.
Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
Clin. Cancer Res. 18: 6599-608, 2012.
[Journal]
4)  Hou Q, Barr T, Gee L, Vickers J, Wymer J, Borsani E, Rodella L, Getsios S, Burdo T, Eisenberg E, Guha U, Lavker R, Kessler J, Chittur S, Fiorino D, Rice F, Albrecht P.
Keratinocyte expression of calcitonin gene-related peptide β: Implications for neuropathic and inflammatory pain mechanisms.
Pain. 152: 2036-51, 2011.
[Journal]
5)  Chalazonitis A, Pham TD, Li Z, Roman D, Guha U, Gomes W, Kan L, Kessler JA, Gershon MD.
Bone morphogenetic protein regulation of enteric neuronal phenotypic diversity: relationship to timing of cell cycle exit.
J. Comp. Neurol. 509: 474-92, 2008.
[Journal]
6)  Guha U, Chaerkady R, Marimuthu A, Patterson AS, Kashyap MK, Harsha HC, Sato M, Bader JS, Lash AE, Minna JD, Pandey A, Varmus HE.
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS.
Proc. Natl. Acad. Sci. U.S.A. 105: 14112-7, 2008.
[Journal]
7)  Guha U, Mecklenburg L, Cowin P, Kan L, O'Guin WM, D'Vizio D, Pestell RG, Paus R, Kessler JA.
Bone morphogenetic protein signaling regulates postnatal hair follicle differentiation and cycling.
Am. J. Pathol. 165: 729-40, 2004.
[Journal]
8)  Chalazonitis A, D'Autréaux F, Guha U, Pham TD, Faure C, Chen JJ, Roman D, Kan L, Rothman TP, Kessler JA, Gershon MD.
Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset.
J. Neurosci. 24: 4266-82, 2004.
[Journal]
9)  Guha U, Gomes WA, Samanta J, Gupta M, Rice FL, Kessler JA.
Target-derived BMP signaling limits sensory neuron number and the extent of peripheral innervation in vivo.
Development. 131: 1175-86, 2004.
[Journal]
10)  Guha U, Gomes WA, Kobayashi T, Pestell RG, Kessler JA.
In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb.
Dev. Biol. 249: 108-20, 2002.
[Journal]
11)  Guha C, Guha U, Tribius S, Alfieri A, Casper D, Chakravarty P, Mellado W, Pandita TK, Vikram B.
Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors.
Gene Ther. 7: 852-8, 2000.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/28/2014.